EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy



Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy



Journal of Urology 167(6): 2361-2367, June



Purpose: We characterize the consequences of androgen deprivation therapy on body composition in elderly men. Materials and Methods: Using a dual energy x-ray absorptiometry instrument, we determined the changes in bone mineral density, bone mineral content, fat body mass and lean body mass in 35 patients with prostate cancer without bone metastases who received luteinizing hormone releasing hormone analogue for 12 months. Results: At baseline conditions 46% of cases were classified as osteopenic and 14% as osteoporotic at the lumbar spine and 40% were osteopenic and 4% osteoporotic at the hip. Androgen deprivation significantly decreased bone mineral density either at the lumbar spine (mean gm./cm.2 (SD) 1.00 (0.194), 0.986 (0.172) and 0.977 (0.182) at baseline, and 6 and 12 months, respectively, p < 0.002) or the hip (0.929 (0.136), 0.926 (0.144) and 0.923 (0.138), p < 0.03). A more than 2% decrease in bone mineral density was found at the lumbar spine in 19 men (54.3%) and at the hip in 15 (42.9%). Bone mineral content paralleled the bone mineral density pattern. Lean body mass decreased (mean gm. (SD) 50,287 (6,656), 49,296 (6,554) and 49,327 (6,345), p < 0.003), whereas fat body mass consistently increased (18,115 (6,209), 20,724 (6,029) and 21,604 (5,923) p < 0.001). Conclusions: Serial bone densitometry evaluation during androgen deprivation therapy may allow the detection of patients with prostate cancer at risk for osteoporotic fractures, that is those with osteopenia or osteoporosis at baseline and fast bone loss. The change in body composition may predispose patients to accidental falls, thus increasing the risk of bone fracture.

Accession: 010292933

Download citation: RISBibTeXText

PMID: 11992038

DOI: 10.1016/S0022-5347(05)64985-3

Download PDF Full Text: Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy



Related references

Changes in bone mineral, lean body mass and fat content as measured by dual energy X-ray absorptiometry: A longitudinal study. Calcified Tissue International 66(2): 97-99, 2000

Whole-body bone mineral content, lean body mass, and fat mass measured by dual-energy X-ray absorptiometry in a population of normal Canadian children and adolescents. Canadian Association of Radiologists Journal 58(1): 46-52, 2007

Quantitative ultrasound of the heel as triage test to measure bone mineral density compared with dual energy X-ray absorptiometry in men with prostate cancer commencing with androgen deprivation therapy. Netherlands Journal of Medicine 72(10): 528-532, 2016

Assessing the accuracy of single photon absorptiometry for predicting total body bone mineral mass and density as measured by dual energy x ray absorptiometry. American Journal of Physical Anthropology (SUPPL 14): 172, 1992

Use of dual-energy x-ray absorptiometry (DEXA) to measure lean body mass, body fat, and bone mineral content (BMC) in dogs and cats. Journal of Veterinary Internal Medicine 10(2): 99-100, 1996

Total body bone mineral and pelvis bone mineral content as parameters of bone mass in men. A dual-energy X-ray absorptiometry study. Acta Anatomica 142(3): 227-230, 1991

Hydration status affects lean body mass but not fat or bone mass as measured by dual energy X-ray absorptiometry. FASEB Journal 10(3): A208, 1996

Total body and regional measurements of bone mineral content and bone mineral density in pigs by dual energy X-ray absorptiometry. Journal of Animal Science 79(10): 2594-2604, 2001

Inverse Correlation at the Hip Between Areal Bone Mineral Density Measured by Dual-Energy X-ray Absorptiometry and Cortical Volumetric Bone Mineral Density Measured by Quantitative Computed Tomography. Journal of Clinical Densitometry 19(2): 226-233, 2016

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. Journal of Bone and Mineral Research 9(5): 631-637, 1994

Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab. Anticancer Research 37(7): 3667-3671, 2017

Behavior of bone mass measurements. Dual energy x-ray absorptiometry total body bone mineral content, ultrasound bone velocity, and computed metacarpal radiogrammetry, with age, gonadal status, and weight in healthy women. Investigative Radiology 31(4): 218-222, 1996

Association between Body Mass Index and Bone Mineral Density in Patients Referred for Dual-Energy X-Ray Absorptiometry Scan in Ajman, UAE. Journal of Osteoporosis 2011: 876309-876309, 2011

Androgen deprivation therapy in patients with prostate cancer and changes in bone mineral density. Journal of Bone & Mineral Research 16(Suppl 1): S243, September, 2001

Mandibular bone mineral density measured using dual-energy X-ray absorptiometry: relationship to hip bone mineral density and quantitative ultrasound at calcaneus and hand phalanges. British Journal of Radiology 73(867): 288-292, 2000